Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.6M Buy
284,486
+6,800
+2% +$785K 0.07% 229
2026
Q1
$33.2M Sell
277,686
-35,159
-11% -$4.61M 0.08% 209
2025
Q4
$42.6M Buy
312,845
+79,959
+34% +$11.5M 0.1% 172
2025
Q3
$34.4M Buy
232,886
+37,300
+19% +$5.17M 0.09% 199
2025
Q2
$25.3M Sell
195,586
-2,081
-1% -$252K 0.06% 247
2025
Q1
$23.6M Sell
197,667
-279,539
-59% -$34.6M 0.07% 221
2024
Q4
$55.4M Buy
477,206
+35,949
+8% +$4.54M 0.17% 101
2024
Q3
$59.6M Buy
441,257
+9,566
+2% +$1.28M 0.2% 88
2024
Q2
$58.6M Sell
431,691
-596,349
-58% -$81.1M 0.22% 81
2024
Q1
$133M Buy
+1,028,040
New +$124M 0.42% 43

Other funds holding XYL

Danske Bank's XYL Position: Q2 2026 in Review

Danske Bank increased its Xylem (XYL) stake by 2.4% in Q2 2026, buying an estimated $785K and bringing the position to 284,486 shares worth $33.6M. The position accounts for 0.07% of the portfolio, ranked #229.

Danske Bank first reported a position in XYL in Q1 2024 and has held it in 10 quarters since. The position peaked at $133M in Q1 2024. 1,098 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Danske Bank held 284,486 shares of Xylem worth $33.6M as of Q2 2026.
  • Danske Bank bought 6,800 Xylem shares in Q2 2026, an estimated $785K.
  • Xylem made up 0.07% of Danske Bank's portfolio in Q2 2026, its #229 holding.
  • Danske Bank first reported a position in Xylem in Q1 2024 and has held it in 10 quarters since.
  • Danske Bank's Xylem position peaked at $133M in Q1 2024.
  • 1,098 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.